Dengue Encephalitis: Don't Forget to List It when the Brain Is HitFunding None.
To the Editor,
An 8-year-old boy, previously well presented with an acute febrile illness for the past week, followed by recurrent, generalized tonic-clonic seizures from day 4 of illness with persistent altered sensorium thereafter. There was no history of focal motor deficits, headache, vomiting, neck pain, trauma, toxin ingestion, recent vaccination, abnormal body odor or rash. On admission, he had depressed sensorium (Glasgow Coma Scale E1V1M2), blood pressure 110/59 mm Hg, pulse rate 98/min, secondary generalized dystonia, rigidity, brisk deep tendon reflexes, extensor plantar responses, and meningismus. A clinical diagnosis of acute encephalitis syndrome (AES) with raised intracranial pressure (ICP) was made. He was mechanically ventilated and ICP control measures were instituted. Empiric intravenous ceftriaxone (50 mg/kg/dose twice daily), doxycycline (3 mg/kg/dose twice daily), and acyclovir (10 mg/kg/dose thrice daily) were administered ([Table 1]).
The rapid diagnostic kit-based dengue nonstructural protein 1 (antigen) was reactive (done at the local hospital on day 4 of illness). His hemoglobin was 10.9 g/dL, total leucocyte count 12.07 × 109/L, and absolute lymphocyte count was 2.88 × 109/L. He had mild thrombocytopenia (1.48 × 109/L), elevated aspartate transaminase (102 IU/L, range 2–40), and alanine transaminase (101 IU/L, range 2–40). Enzyme-linked immunosorbent assay-based dengue IgM titers were elevated. Cerebrospinal fluid analysis (CSF) by lumbar puncture showed absence of cells, glucose 72 mg/dL, protein 52 mg/dL, and absence of bacteria on Gram Stain or culture. Polymerase chain reaction for herpes viral DNA was negative. Antibody titers for Japanese encephalitis virus in CSF by IgM ELISA were not elevated. Dengue antibodies in CSF were not done as it was not available. Magnetic resonance imaging (MRI) of the brain showed features of encephalitis and the characteristic “double doughnut sign” ([Fig. 1A–D]). A final diagnosis of dengue encephalitis was considered. With supportive care, he gradually improved. At discharge, he was able to understand simple commands, recognized parents, and sat with support.
Dengue fever is a multisystemic infection caused by the dengue virus. The virus belongs to the Flaviviridae family and is spread by the mosquito Aedes aegypti. Dengue is endemic in most parts of India and peaks after the monsoon season. It is one of the common causes of AES in India after Japanese encephalitis (JE) and scrub typhus.  Patients with dengue encephalitis may not have all the typical manifestations of dengue fever such as petechial rash and bleeding manifestations.
The diagnosis in the index case was suspected on the basis of the clinical syndrome of AES, thrombocytopenia, transaminitis, absence of a bacterial picture in the CSF, and dengue antigen and IgM positivity in the serum. MRI in dengue encephalitis may show cortical swelling, signal changes in the cerebral (40%) and cerebellar white matter (31%), brain stem (28%), thalamus (26%), middle cerebellar peduncles (23%), or basal ganglia (6%). Hyperintense signal in bilateral thalami with central diffusion restriction and blooming on susceptibility-weighted imaging has been described as a peculiar “double-doughnut sign” in dengue encephalitis. It is often seen in adult patients. The neurological presentation of JE and dengue encephalitis may be similar, but dengue often presents with marked systemic features such as rash, organomegaly, transaminitis, serous effusions, arthralgia, and myalgia. Therefore, it is important to differentiate among these two illnesses. JE presents with leucopenia, CSF pleocytosis, elevated CSF protein, generalized dystonia, and signal changes in the thalamus and basal ganglia. JE has significant mortality and neurological morbidity, whereas dengue encephalitis has the potential for good recovery with minimal neurological deficits as in the index case. In conclusion, doughnut sign on the MRI is an important clue to dengue encephalitis in children with AES and needs timely recognition.
Received: 18 June 2020
Accepted: 28 July 2020
04 September 2020 (online)
Georg Thieme Verlag KG
Stuttgart · New York
- 1 Mutheneni SR, Morse AP, Caminade C, Upadhyayula SM. Dengue burden in India: recent trends and importance of climatic parameters. Emerg Microbes Infect 2017; 6 (08) e70
- 2 Vasanthapuram R, Shahul Hameed SK, Desai A. , et al. Dengue virus is an under-recognised causative agent of acute encephalitis syndrome (AES): results from a four year AES surveillance study of Japanese encephalitis in selected states of India. Int J Infect Dis 2019; 84S: S19-S24
- 3 Jain P, Jain A, Kumar A. , et al. Epidemiology and etiology of acute encephalitis syndrome in North India. Jpn J Infect Dis 2014; 67 (03) 197-203
- 4 Solomon T, Dung NM, Vaughn DW. , et al. Neurological manifestations of dengue infection. Lancet 2000; 355 (9209): 1053-1059
- 5 Vanjare HA, Mannam P, Mishra AK. , et al. Brain imaging in cases with positive serology for dengue with neurologic symptoms: a clinicoradiologic correlation. AJNR Am J Neuroradiol 2018; 39 (04) 699-703
- 6 Shah N, Nair AV, Ahamed S, Manoj KS. Dengue doughnut: a diagnostic magnetic resonance imaging finding in dengue encephalitis. J Postgrad Med 2018; 64 (02) 127
- 7 Garg RK, Malhotra HS, Jain A. Dual infection with Japanese encephalitis and dengue fever: issues with diagnosis. Neurol India 2017; 65 (01) 108-109
- 8 Kankirawatana P, Chokephaibulkit K, Puthavathana P, Yoksan S, Apintanapong S, Pongthapisit V. Dengue infection presenting with central nervous system manifestation. J Child Neurol 2000; 15 (08) 544-547